Literature DB >> 3965498

Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding.

E Dejana, L R Languino, N Polentarutti, G Balconi, J J Ryckewaert, M J Larrieu, M B Donati, A Mantovani, G Marguerie.   

Abstract

It has been suggested that fibrinogen (fg) or its physiological derivatives influence the motility and growth of endothelial cells (ECs), but direct support for this concept is still lacking. In the present study, the capacity of fg to interact with ECs and induce the migration of ECs was examined. The capacity of fg to induce EC migration was studied by means of a modification of the Boyden chamber technique. fg in the lower compartment of the chamber caused a time- and concentration-dependent migration of ECs across filters. fg present in equal concentrations above and below the filter increased EC migration, but the maximal effect invariably occurred in the presence of a gradient between the lower and the upper compartments. Trypsin or plasmin digestion of fg and preincubation of fg with Fab fragments from specific antibody completely abolished fg-induced EC migration. Dialysis of fg to eliminate small peptides that might contaminate the preparation did not modify fg-induced migration. Plasma obtained from healthy donors induced EC migration, but plasma from an afibrinogenemic patient was completely ineffective. The addition of purified fg to afibrinogenemic plasma restored plasma-induced EC migration. Plasmin degradation fragments D and E, of 100,000 and 50,000 mol wt, respectively, did not induce EC migration. However, fragment E caused dose-related inhibition of fg-induced EC migration Direct interaction of highly purified radioiodinated human fg with cultured human and bovine Ecs was observed. The binding was time dependent and plateaued at 10 min. Nonlabeled fg in a large molar excess inhibited the interaction, but unrelated proteins, including fibronectin, ovalbumin, and myoglobin, did not. Monospecific Fab fragments directed to fg inhibited binding by 38% at a 50 to 1 molar ratio whereas nonimmune Fab caused only 2% inhibition at a similar concentration. The binding of 125I-fg with ECs was saturable, and an apparent dissociation constant of 0.23 x 10(-6) M was estimated from binding isotherms. After 30 min of incubation the interaction between 125I-fg and the cells was completely reversible and displaceable by a large molar excess of unlabeled fg. Autoradiography of the display of EC-bound 125I on polyacrylamide gel showed the constitutive B beta- and gamma-chains of the fg molecule, with a partial loss of the A alpha-chain. Purified fragment E and E were tested for their capacity to inhibit fg binding. At a 1 to 400 125I-fg-to-fragment molar ratio, fragment E, which also inhibited migration, competed for binding by 44%, but fragment D was completely ineffective. These data show that fg may specifically associate with ECs and induce migration of these cells; it also appears that the structural requirement of this activity is located in the N-terminal part of the molecule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965498      PMCID: PMC423387          DOI: 10.1172/JCI111661

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Human platelets possess an inducible and saturable receptor specific for fibrinogen.

Authors:  G A Marguerie; E F Plow; T S Edgington
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

2.  Exposure of fibrinogen receptor on human platelets by proteolytic enzymes.

Authors:  S Niewiarowski; A Z Budzynski; T A Morinelli; T M Brudzynski; G J Stewart
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

3.  Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells.

Authors:  D M Center; W Cruikshank
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

4.  Epidermal growth factor-urogastrone: biological activity and receptor binding of derivatives.

Authors:  M D Hollenberg; H Gregory
Journal:  Mol Pharmacol       Date:  1980-05       Impact factor: 4.436

Review 5.  Malignancy and haemostasis.

Authors:  M B Donati; A Poggi
Journal:  Br J Haematol       Date:  1980-02       Impact factor: 6.998

6.  Adult tissues contain chemoattractants for vascular endothelial cells.

Authors:  B M Glaser; P A D'Amore; H Seppa; S Seppa; E Schiffmann
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

7.  Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.

Authors:  H F Dvorak; A M Dvorak; E J Manseau; L Wiberg; W H Churchill
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

8.  Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts. Association with fibronectin (cold insoluble globulin, LETS protein) and loss in SV40 transformed cells.

Authors:  R B Colvin; P I Gardner; R O Roblin; E L Verderber; J M Lanigan; M W Mosesson
Journal:  Lab Invest       Date:  1979-11       Impact factor: 5.662

9.  Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.

Authors:  D Meyer; B Obert; G Pietu; J M Lavergne; T S Zimmerman
Journal:  J Lab Clin Med       Date:  1980-04

10.  The interaction of fibrinogen with human platelets in a plasma milieu.

Authors:  G A Marguerie; N Thomas-Maison; M J Larrieu; E F Plow
Journal:  Blood       Date:  1982-01       Impact factor: 22.113

View more
  55 in total

1.  Purification, molecular cloning and mechanism of action of graminelysin I, a snake-venom-derived metalloproteinase that induces apoptosis of human endothelial cells.

Authors:  W B Wu; S C Chang; M Y Liau; T F Huang
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

Review 2.  Tissue engineering in the vascular graft.

Authors:  S P Massia; J A Hubbell
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

3.  Lack of effect of thrombin on fibrin(ogen)-endothelial cell interaction.

Authors:  E Réganon; V Vila; V Martínez-Sales; J Aznar
Journal:  Cytotechnology       Date:  1995-06       Impact factor: 2.058

4.  Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.

Authors:  G Montrucchio; E Lupia; A de Martino; E Battaglia; M Arese; A Tizzani; F Bussolino; G Camussi
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

5.  Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia.

Authors:  V Annaix; J P Bouchara; G Larcher; D Chabasse; G Tronchin
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma.

Authors:  Jun Du; Jian-Hua Zheng; Xu-Sheng Chen; Qing Yang; Yan-Hui Zhang; Lei Zhou; Xin Yao
Journal:  Int J Clin Oncol       Date:  2012-05-19       Impact factor: 3.402

7.  Immunologic relationship between platelet membrane glycoprotein GPIIb/IIIa and cell surface molecules expressed by a variety of cells.

Authors:  E F Plow; J C Loftus; E G Levin; D S Fair; D Dixon; J Forsyth; M H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 8.  Vascular endothelial growth factor: environmental controls and effects in angiogenesis.

Authors:  L Hlatky; P Hahnfeldt; C Tsionou; C N Coleman
Journal:  Br J Cancer Suppl       Date:  1996-07

9.  Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1α and hypoxia-inducible transcription factor-2α.

Authors:  Aftab Ahmad; Shama Ahmad; Kenneth C Malcolm; Stacy M Miller; Tara Hendry-Hofer; Jerome B Schaack; Carl W White
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

Review 10.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.